Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1110524

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Priorities Advisory Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the NHS has to utilise the NICE Commissioning Support Programme for the development of national clinical policies not yet scheduled for review by the Clinical Priorities Advisory Group.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	242832
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>I refer the hon. Member to the answers I gave on 10 April 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-02/239979/" target="_blank">239979</a>, <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239980+" target="_blank">239980</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239981" target="_blank">239981</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 242833 242834 question first answered 12/04/2019 14:05:46 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1110525

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Priorities Advisory Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to enable members of the public to attend meetings of the Clinical Priorities Advisory Group.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	242833
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>I refer the hon. Member to the answers I gave on 10 April 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-02/239979/" target="_blank">239979</a>, <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239980+" target="_blank">239980</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239981" target="_blank">239981</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 242832 242834 question first answered 12/04/2019 14:05:46 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1110526

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timeframe is for the roll-out of the use of patient impact reports as part of the clinical policy development process.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	242834
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>I refer the hon. Member to the answers I gave on 10 April 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-02/239979/" target="_blank">239979</a>, <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239980+" target="_blank">239980</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=239981" target="_blank">239981</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 242832 242833 question first answered 12/04/2019 14:05:46 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1110530

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the incidence of cancer caused by obesity.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	242838
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>I refer the hon. Member to the answer I gave on 9 April 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-02/239986/" target="_blank">239986</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 12/04/2019 14:01:34 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1110532

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Arthritis: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to support children with arthritis.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	242840
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>In the United Kingdom, about 15,000 children and young people are affected by arthritis, with approximately 1,000 children diagnosed with juvenile idiopathic arthritis (JIA) per year. JIA may continue into adulthood, and about a third or more of children with the condition still need treatment in adult life.</p><p> </p><p>Support for patients with long term health problems should include provision of a holistic assessment and the development of a personalised care plan, taking into account their needs and preference for care. Treatment for JIA can include anti-inflammatory drugs, steroids and disease modifying anti-rheumatic drugs (DMARDs), such as Methotrexate to suppress the immune response creating the inflammation. For patients who do not respond to DMARDs, the National Institute for Health and Care Excellence has approved several biological therapies (anti-tumour necrosis factor drugs), which work in a similar way to DMARDs, but are more targeted in addressing the immune response.</p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in a range of areas to improve the care and support for children and young people. From 2019/20 clinical networks will be rolled out to improve the quality of care for children with long-term conditions. This will be achieved though sharing best clinical practice, supporting the integration of paediatric skills across services and bespoke quality improvement projects.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 12/04/2019 13:49:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1110537

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the effectiveness of the implementation of the guidance entitled Items which should not be routinely prescribed in primary care: Guidance for CCGs.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	242690
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>We are informed by NHS England that in the period up to and including October 2018, spend on the 18 low priority medicines has fallen by £31.1 million from £133.6 million, compared to 2016/17. This represents a reduction of 23%.</p><p> </p><p>The volume of medicines prescribed reduced by 27% and the number of patients prescribed these medicines reduced by 32%.</p><p> </p><p>In addition, NHS England has worked with PrescQIPP and the NHS Business Services Authority to refine its assessment of the amount of money spent on over the counter medicines.</p><p> </p><p>In the 12 months to January 2019, the total National Health Service spend in England on over the counter medicines was £449.4 million. This was a saving on total spend of £25.9 million from the 12 months to January 2018, which was £475.3 million. This saving does not account for the potential impact to the NHS from a reduced number of general practitioner appointments, for which no assessment has been made.</p><p> </p><p>These savings will be reinvested into the NHS, ensuring patients can access high quality care now and in the future.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:04 answering member 4455 label Biography information for Seema Kennedy
tabling member	392 label Biography information for Sir Kevin Barron

1110552

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	242693
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	394 label Biography information for Mr Clive Betts

1110659

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 December to Question 198332 on Sickle Cell Diseases: Prescriptions, what assessment he has made of the effect on BAME patients of his policy not to include sickle cell anaemia in the list of conditions for which a medical exemption certificate can be obtained.
tabling member constituency	Greenwich and Woolwich
tabling member printed	Matthew Pennycook
uin	242910
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>The Department has made no assessment. This is because there are extensive arrangements in place to ensure that people can access affordable prescriptions. To support those with the greatest need who do not qualify for an exemption, prescription prepayment certificates are available.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 12/04/2019 14:07:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	4520 label Biography information for Matthew Pennycook

1110760

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pain: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the recommendations on page 75 of the Faculty of Pain Medicine published in The Core Standards for Pain Management Services and the recommendations on page 8 of the General Medical Council published in Good practice in prescribing and managing medicines and devices, what assessment he has made of the potential benefit to people with chronic pain of receiving an annual review for their pain management services.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	242797
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>No specific assessment has been made of the potential benefit to people with chronic pain of receiving an annual review for their pain management services.</p><p> </p><p>Whilst ultimately a matter for local processes and individual clinicians, annual reviews of patients with long term conditions or ongoing medication needs are a routine part of patient care. Annual reviews are also a key feature in guidance on the management of long-term diseases and disorders produced by the National Institute for Health and Care Excellence (NICE), such as ‘Neuropathic pain in adults’, and in clinical guidance produced by other organisations. NICE is in the process of developing a new clinical guideline ‘Chronic pain: assessment and management’, due for publication in August 2020.</p><p> </p><p>More information about this work can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/indevelopment/gid-ng10069" target="_blank">www.nice.org.uk/guidance/indevelopment/gid-ng10069</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 12/04/2019 14:04:19 answering member 4455 label Biography information for Seema Kennedy
tabling member	3957 label Biography information for Martin Vickers

1110804

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a high level of up-take of the HPV vaccine throughout the country.
tabling member constituency	Livingston
tabling member printed	Hannah Bardell
uin	242896
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>Coverage of the human papillomavirus (HPV) vaccine in teenage girls is high with nearly 84% receiving the full course of vaccine. Public Health England (PHE) developed a range of materials targeted at teenagers and their parents to provide information about the HPV vaccination programme to help them make an informed choice. Local immunisation providers should share this information and signpost teenagers and their parents to these materials when the offer of HPV vaccination is underway in schools. These materials can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/immunisation#human-papillomavirus-(hpv)-for-girls" target="_blank">https://www.gov.uk/government/collections/immunisation#human-papillomavirus-(hpv)-for-girls</a></p><p> </p><p>PHE also provides information and training materials for health professionals to ensure they can adequately respond to queries or concerns. These training materials can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a" target="_blank">https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a</a></p><p> </p><p>In addition, PHE has also worked closely with several charities such as Jo’s Cervical Cancer Trust and the Teenage Cancer Trust to develop lesson plans for schools to use to teach young people about cervical cancer and the HPV vaccine. These can be seen at the following links:</p><p> </p><p><a href="https://www.jostrust.org.uk/information-healthcare-professionals/information-teachers" target="_blank">https://www.jostrust.org.uk/information-healthcare-professionals/information-teachers</a></p><p> </p><p><a href="https://www.teenagecancertrust.org/about-us/what-we-do/cancer-awareness/resources#cervicalcancer" target="_blank">https://www.teenagecancertrust.org/about-us/what-we-do/cancer-awareness/resources#cervicalcancer</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:53:23 answering member 4455 label Biography information for Seema Kennedy
tabling member	4486 label Biography information for Hannah Bardell